1. Introduction
Environmental degradation and disease are the two major challenges of this century. This study explores a novel solution to deal these issues by addressing the accumulated coral remains in Taiwan and their potential application in cancer drug development, one of the leading causes of death worldwide. Coral remains are composed of coral fragments resulting from weathering, waves, or trampling. It is a unique environmental issue in Taiwan. Despite coral remains being non-toxic and harmless, the accumulation of coral causes lots of problems along the coast in Penghu, one of the counties in Taiwan. Coral remains accumulating along the coast lead to a reduction in marine life living spaces and the obstruction of fishing routes, impacting fishermen’s livelihoods. The local government tried to dredge the coral remains and place them onto the beach. Unfortunately, the resulting odor and damage to the landscape continued to constitute serious problems. Coral remains consist of CaCO3, which is known as a safe, cheap, and clean industrial mineral. Compared to oyster shells, coral remains do not require a significant amount of time for washing and cleaning, making them an ideal material for this study.
Cancer is one of the most critical issues around the world. The International Agency for Research on Cancer (IARC) and the Union for International Cancer Control (UICC) reported nearly 19.3 million cancer cases, with the death toll reaching up to 10 million in 2020 [
1]. Moreover, cancer has been the leading cause of death in Taiwan since 1982, accounting for 28.98% of all deaths in 2020, totaling 50,161 people [
2]. Due to the toxicity of cancer drugs, the precision of drug delivery is a significant feature in curing cancers. Therefore, a growing amount of research is committed to loading drugs into unique containers to improve the precision of drug delivery, i.e., drug carriers [
3,
4]. There is currently a variety of drug carriers such as liposomes, solid lipid nanoparticles, gold nanoparticles, etc. However, they still have some critical problems that must be dealt with, e.g., bio-toxicity, aggregation, and high cost.
CaCO
3 is a promising and novel material for drug carriers. It possesses several properties, including high biocompatibility, substantial drug loading capacity, pH sensitivity, low cost, and the capability to carry multiple drugs simultaneously [
5,
6,
7,
8,
9]. It is widely used as an industrial mineral [
10,
11,
12,
13,
14,
15,
16,
17,
18,
19] and a raw material for pharmaceutical products [
20,
21]. CaCO
3 has been utilized as a carrier to deliver proteins and genes [
22]. Therefore, the public acceptability of CaCO
3 is better than that of other materials. Moreover, according to the report from Vikulina et al. [
23], CaCO
3 costs only 0.2–0.4 USD/g, which is significantly lower than the 100 USD/g cost of liposomes.
CaCO
3 is widely used in industry as a filler. It can not only lower the cost but also improve the properties of products [
24,
25]. CaCO
3 has three major anhydrous phases: calcite, aragonite, and vaterite [
26,
27]. Calcite is the most stable phase among them, followed by aragonite and vaterite [
28,
29,
30,
31]. Vaterite is the least stable but the most promising phase for a drug carrier due to its high porosity, large surface, and higher solubility. Vaterite will gradually dissolve and recrystallize into calcite in water, which is an imperative mechanism for drugs to be released from vaterite (
Figure 1). Owing to the instability of vaterite, the synthesizing process must be studied to control the morphology, particle size, and purity of it. To manipulate the morphologies and particle sizes of CaCO
3, the addition of additives is the general approach for achieving this [
32,
33,
34,
35,
36,
37,
38]. Parakhonskiy et al. reported that polyol can inhibit CaCO
3 from growing into other phases [
39]. Thus, we used ethylene glycol (EG) as an additive to maintain the vaterite phase [
40,
41,
42]. EG can also control the particle size of vaterite, as studies have indicated that cancer cells take up molecules smaller than 600 nm selectively due to the enhanced permeability and retention effect (EPR effect) [
43].
2. Materials and Methods
2.1. Materials
Coral remains from Penghu coastal accumulations and dredging operations were used as the raw material for this study. Coral remains were collected by scholars from Penghu University of Science and Technology. The dredging operations were carried out by the Penghu government. The coral remains were dredged and placed along the coast so that we could easily collect them with permission from the government.
2.2. Pretreatment and Characteristic Analysis of Coral Remains
Coral remains underwent washing, hydrogen peroxide immersing, drying, and grinding, followed by 60-mesh sieving. For elemental analysis, the sample was calcined at 1000 °C for 4 h, then dissolved in a mixture of aqua regia and hydrofluoric acid (HF) in the ratio of 9:1. Following these procedures, the solution was analyzed using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES, Avio 200 Manx, PerkinElmer, Waltham, MA, USA).
2.3. Purification of Coral Remains and Preparation of CaCl2
Purification began with the calcination of coral remains at 1000 °C to decompose them into CaO, which was then dissolved in water to form Ca(OH)
2. This step was followed by a reaction with CO
2, resulting in the precipitation of CaCO
3. The calcination was carried out in a tube furnace under different atmospheres (air, N
2, and CO
2) to study the decomposition rate of CaCO
3 in varying conditions. The calcination temperatures in air and N
2 were set between 700 °C and 1200 °C. In the case of CO
2, temperatures ranged from 500 °C to 1000 °C due to no significant improvement observed beyond 700 °C, prompting the extension down to 500 °C. The decomposition rates of CaCO
3 were calculated using the following equation (Equation (1)), where x represents the decomposition rate and 44 is the molecular weight of CO
2. The purity of the resulting CaCO
3 was confirmed using ICP-OES, and it was subsequently reacted with HCl to produce CaCl
2, as shown in the following equations (Equations (2) and (3)):
2.4. Exploration of Optimal Parameters for the Synthesis of Vaterite
Solutions with different concentrations of CaCl2 and Na2CO3 were prepared and injected into EG in specific ratios. Further steps included centrifugation, washing, and drying at 60 °C for 2 h. Given the complex reaction mechanism involved in vaterite formation, a thorough investigation was conducted to gain a comprehensive understanding of its reaction mechanisms and characteristics. This involved exploring a range of parameters, such as the concentration of EG, stirring speed, total reaction time, initial salt concentration, reaction volume, and the adding order of CaCl2 and Na2CO3. The particle size and crystal phase variations of CaCO3 under these different conditions were carefully observed to identify the optimal synthesis parameters. For examining the vaterite crystal structure, Scanning Electron Microscopy (SEM, Hitachi SU-1510, Tokyo, Japan) was utilized, with the samples being coated with a palladium (Pd) layer. The particle size distribution was quantified using ImageJ Version 1.54h, with a sample size of N 150 particles per sample.
2.4.1. Adding Order of the Salts
CaCO3 was synthesized using the precipitation method, involving CaCl2 and Na2CO3. We found that the order in which these salts are added plays a critical role, a parameter not extensively discussed in the existing literature. Altering the sequence of adding CaCl2 and Na2CO3 resulted in significant variations in the crystal forms and particle sizes of the synthesized CaCO3. Therefore, the impact of the adding order of these salts was emphasized in this study.
2.4.2. Stirring Speed
This section examined the effect of various stirring speeds (400, 600, 800, 1000, and 1150 rpm) on the particle size of CaCO3.
2.4.3. EG Concentration
Ethylene glycol (EG) played a critical role in this study due to its high viscosity, which decelerates ion diffusion and inhibits the growth of CaCO3. We investigated various EG concentrations, including 0%, 25%, 50%, and 85%, to determine their impact on the synthesis of CaCO3.
2.4.4. Reaction Time
The presence of EG is known to mitigate the reaction speed. We explored how varying reaction times influence the diversity of CaCO3 formations. In this study, time intervals of 1 min, 30 min, 60 min, 180 min, and 1440 min (1 day) were examined to determine the optimal reaction duration.
2.4.5. Initial Salt Concentration
Nucleation theory suggests that the initial salt concentration can impact the nucleation rate, consequently affecting the particle size. This study varied the initial concentrations of CaCl2 and Na2CO3 to observe the resulting changes in CaCO3 and to validate the alignment of our findings with the nucleation theory.
2.4.6. Total Reaction Volume
This investigation explored the effects of different total reaction volumes, including the combined volumes of salt solutions and EG. Contrasting with the common practice in the literature, which typically synthesizes CaCO3 using drug carriers around 100 mL, we extended this range to include volumes of 4 mL, 40 mL, 120 mL, and 400 mL to investigate the formation and characteristic of CaCO3.
2.5. Drug Loading Simulation Experiment
The fluorescently labeled drug Tetramethylrhodamine Isothiocyanate–Dextran (TRITC-Dextran) was utilized for loading into CaCO
3 carriers, and the loading capacity (LC) was subsequently calculated after drug loading. For LC calculation, an indirect method [
44] was employed. This method involves analyzing the concentration of the drug in the supernatant collected after centrifugation the drug-loaded carrier. The LC is then estimated by deducting the drug concentration in the supernatant from the initial drug concentration. The concentration of TRITC-Dextran was maintained at 10 mg/mL in this study. We analyzed the collected supernatant using a Fluorescence Spectrophotometer (Fluorescence Spectrophotometer, Hitachi High-Tech F-7000, Hitachi High-Technologies Corporation, Tokyo, Japan). The drug-loaded carriers were examined under a confocal microscope (Confocal Microscope, Carl Zeiss LSM780, Carl Zeiss AG, Oberkochen, Germany) to assess the amount of TRITC-Dextran loaded into the CaCO
3 particles. An excitation wavelength of
nm was utilized in this study. The drug concentration in the supernatant was calculated using the following equation (Equation (4)):
where
represents the intensity of fluorescence,
is the incident power,
is the molar absorptivity,
is the path length,
is the concentration,
is the quantum efficiency, and
is the ratio of photons measured to photons emitted. Typically,
,
, b,
, and k are constant, making the concentration in the supernatant directly proportional to the fluorescence intensity F.
4. Conclusions
Compared to other calcium-rich biogenic wastes such as oyster and clam shells, coral remains at present to be a cleaner and more easily collected alternative. This study, initiated from a circular economy perspective, investigated the potential of repurposing coral remains, a topic typically associated with environmental challenges, into a valuable raw material for better use. The major composition of coral remains is CaCO3, a common raw material in industrial and pharmaceutical products. In this study, coral remains could meet the industrial standards for CaCO3 undergoing a series of purification and modification processes. Vaterite, one of the crystal phases of CaCO3, demonstrated excellent physicochemical properties, making it a promising material for anticancer drug carriers. The conclusions drawn from the experiments are as follows:
The composition analysis of coral remains showed the absence of heavy metals such as Pd and Cd, both of which are of most concern in food and pharmaceutical products, indicating their suitability as raw materials for these industries.
The efficient conversion of CaCO3 to CaO in an N2 atmosphere at 800 °C within just 5 min demonstrates a significant enhancement in process efficiency, potentially reducing both time and cost.
The whiteness level of purified CaCO3 reached 95%, surpassing many industrial standards (93%), making it suitable for industrial applications.
The synthesized vaterite possesses several desirable drug carrier properties such as spherical morphology, small particle size, high porosity, pH sensitivity, and biocompatibility. Given its widespread use in the food and pharmaceutical industries, CaCO3 has shown to be a superior option for anticancer drug delivery compared to other drug carriers such as mesoporous silica nanoparticles and gold nanoparticles.
The effective utilization of the EPR effect for targeting cancer cell necessitates particle sizes below 600 nm. Smaller particles are more efficient in penetrating cell membranes and also positively impact the drug loading capacity, a crucial factor of the efficiency of CaCO
3 as a drug carrier. While typical reproducibility of vaterite particle size range from 4 to 6 µm [
40,
50,
51], our study successfully synthesized drug carriers with an average size of 344 nm, and some even smaller than 200 nm.
During CaCO3 synthesis, the involvement of EG necessitated sufficient time to form a complete vaterite crystal. Insufficient time resulted in the formation of either amorphous phases or incomplete calcite crystals.
Given the high costs associated with cancer drug production and the expensive, intricately synthesized carriers typically used for their delivery, the overall price of anticancer drug carriers remains notably high. CaCO3, in contrast, is a widely available, cost-effective, and stable material. Its application as a drug carrier could significantly reduce costs while maintaining excellent biocompatibility and precision in drug delivery. This approach not only provides a solution to the high expenses involved in synthesizing drug carriers, but also tackles environmental concerns related to coral remains, offering a dual advantage.